Analyst Ratings for ArriVent BioPharma (AVBP)
AVBP Rating Summary
AVBP Price Target Summary
- Highest: $50.00 (Oppenheimer)
- Lowest: $33.00 (Goldman Sachs)
- Average: $43.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$43.56 (+37.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/29/2026 | Truist Securities | Supawat Thongthip | New Coverage | Buy (N/A) |
45.00 (N/A) |
26.97 (31.74) |
17.69% | Details |
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
45.00 (N/A) |
24.89 (31.74) |
27.52% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
